Press release
Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property.
Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property.The intellectual property is available on the scientific collaboration platform, Therapoid™.
Minneapolis, MN– August 7, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, received dormant intellectual property (IP) from the Oklahoma Medical Research Foundation (OMRF).
According to Jason E. Barkeloo, Founder and Chair of Open Therapeutics, “Open Therapeutics in-licenses and accepts dormant, orphan, and abandoned IP from institutions and organizations around the world. That IP is freely provided to scientists on the Therapoid™ platform. Along with grants, lab equipment, communication tools, manuscript development tool, career opportunities, and preprint server, researchers can collaborate with peers to advance the freely provided IP.”
The OMRF IP available in Therapoid™ ranges from proteins and a central nervous system treatment for Alzheimer’s, to novel multiple sclerosis (MS) treatments and pluripotent stem cells.
According to Jerome Hamilton, “We are pleased to represent this intellectual property from the Oklahoma Medical Research Foundation as we do our part in making the world a better place with therapeutic discoveries. Open Therapeutics will continue to add value for scientists while facilitating a world class experience as they collaborate with their peers on the Therapoid™ platform.”
The OMRF IP is listed on the Therapoid™ platform, which is in alpha release at https://Therapoid.net.
About Open Therapeutics LLC
Open Therapeutics (http://OpenTherapeutics.org) is an intellectual property firm that creates and attracts therapeutic technologies and crowdsources them for use by the global scientific community. Researchers can freely access the intellectual properties, funding, lab equipment, manuscript development tool, and preprint server to further the development of the therapeutic technologies (medical devices, pharma, diagnostics) at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with operations in Cincinnati, OH, Amman, Jordan, and Bangalore, India.
Contact: Jerome Hamilton, CEO, Open Therapeutics
+1.651.900.0412
Jerome@OpenTherapeutics.org
Twitter: @OpenTherapeutic
Telegram: https://t.me/OpenTherapeutics
Open Therapeutics (http://OpenTherapeutics.org) is an intellectual property firm that creates and attracts therapeutic technologies and crowdsources them for use by the global scientific community. Researchers can freely access the intellectual properties, funding, lab equipment, manuscript development tool, and preprint server to further the development of the therapeutic technologies (medical devices, pharma, diagnostics) at Therapoid™ (https://Therapoid.net). The Company is headquartered in Minneapolis, MN, with operations in Cincinnati, OH, Amman, Jordan, and Bangalore, India.
Open Therapeutics
P.O. Box 30085
Cincinnati, OH 45230
Contact: Jerome Hamilton, CEO, Open Therapeutics
+1.651.900.0412
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Open Therapeutics Receives Oklahoma Medical Research Foundation’s Dormant Intellectual Property. here
News-ID: 1167567 • Views: …
More Releases from Open Therapeutics
Open Therapeutics and American Impact Capital Foundation Form Alliance
American Impact Capital Foundation Provides Non-Fungible Token (NFT) and Cryptocurrency Holders a Route for Philanthropic and Charitable Giving.
Cincinnati, OH and Westport, CT - December 12th, 2022 - Open Therapeutics [ https://OpenTherapeutics.org ], an open science company, announces an alliance with American Impact Capital Foundation [ https://americanimpactcapital.com/ ]. Through this alliance, members of the Open Therapeutics' Therapoid [ https://Therapoid.net/ ] community who wish to donate their NFTs and cryptocurrency assets…
Open Therapeutics is Awarded a Grant from the Blockchain-based Polygon Decentral …
Through this award, Open Therapeutics will accelerate its Web3.0 Polygon blockchain implementation.
Cincinnati, OH, and Polygon DAO - November 8, 2022 - Open Therapeutics (https://OpenTherapeutics.org), an open science company was awarded a grant from the leading blockchain developer organization, the Polygon Decentralized Autonomous Organization (Polygon DAO).
The PolygonDAO is a global blockchain developer community that aims to decentralize, grow, and innovate the Polygon blockchain community. With over 68,000 members in its Official…
Open Therapeutics and IPwe Form an Intellectual Property Partnership.
Through a partnership to enhance the licensing of intellectual properties, the companies will work to jointly encourage the licensing of IP portfolios
Cincinnati, OH, and Paris, France - September 14th, 2022 - Open Therapeutics, an open science company, and IPwe, a global platform leveraging the power of artificial intelligence, predictive analytics, and blockchain technology around smart intangible asset management, announce their collaboration to jointly advance the licensing of intellectual property.
Open Therapeutics'…
Timmaron Group of Minnesota invests in Open Therapeutics, LLC
Open Therapeutics, LLC owns Therapoid. Therapoid is a scientific collaboration platform that crowdsources scientists, particularly the underserved in Africa, Asia, and Latin America, around freely provided Intellectual property. Therapoid not only provides IP, but grants, free lab equipment, manuscript development tools, and preprint server for achieving open access publications and pushing technology development forward. For more information about Open Therapeutics visit (https://OpenTherapeutics.org) or visit (https://Therapoid.net) to register.
…
More Releases for Therapoid™
Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management …
Open Therapeutics and doDOC™ Partner to Integrate doDOC™ Content Management System into Therapoid™.
Innovative manuscript development tool to be integrated into scientific collaboration platform.
Minneapolis, MN and Boston, MA – June 27, 2018 – Open Therapeutics LLC, a scientific collaboration platform company, and doDOC, a online collaborative writing tool that allows researchers to plan, draft, edit, review and approve professional documents more than 70% faster, have partnered. Therapoid™ will freely…
MetaFix™ PlantarMAX™ Foot Plate received FDA-Release
Merete Medical GmbH announces the FDA-approval for MetaFix™ PlantarMAX™ plate. PlantarMAX™ is designed as the first plantar/medial Lapidus fixation plate which takes advantage of the biomechanically superior fixation on the tension side of the Metatarsal/Cuneiform joint during a Lapidus Hallux Valgus correction procedure. The fixation on the tension side of the joint is superior to dorsal or medial fixation and offers additional compression as the patient proceeds to weight bearing.
Merete…
Dali Wireless™ Introduces its Low Power t-Series Solution: tHost™ and t30™
Palo Alto, October 25, 2012 – Dali Wireless, a leader in next generation wireless infrastructure, today announced the release of its low power t-Series solution, which consists of the t30 remote unit and the tHost head-end.
The exponential growth of mobile data capacity is challenging traditional cellular networks. Dali Wireless has created a unique solution to address these capacity limitations by combining industry standard protocols with the culmination of over…
GFI™ Software Announces GFI LANguard™ 2011
Clearwater, FL – May 23, 2011 – GFI Software’s Infrastructure Business Unit today announced the launch of GFI LANguard™2011, the latest version of the company’s comprehensive network vulnerability scanning and patch management solution. GFI LANguard 2011 is the first network vulnerability and patch management solution to integrate with more than 1,500 security applications and to include keyword search functionality, illustrating GFI’s commitment to providing small and medium-sized businesses (SMBs) with…
Pixelmetrix to launch Consolidator™, its new generation Network Management Sys …
Singapore – April 1, 2011 – Pixelmetrix, the global expert in Preventive Monitoring for digital television and IPTV networks, is set to launch Consolidator™, its new generation Network Management System, StationView™ for Simple, Effective Monitoring and the Electronic Couch Potato™ (ECP) Video Quality Index™ (VQI) for video quality verification.
Consolidator™ provides centralized access and visibility of key network fault and performance information. Scalable to thousands of probes and millions of…
SaferWatch™ announces TIN Manager™
HEBRON, ND – SaferWatch announces the release of their latest software solution, TIN Manager™. The TIN Manager feature is designed to verify the accuracy of Taxpayer Identification Number (TIN) and name information prior to submitting 1099’s to the IRS so that the company will not be penalized or fined for mismatches.
TIN Manager eliminates tax preparation hassles by giving the bookkeeping departments of broker and shipper businesses a…
